Raymond James & Associates’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $258K | Buy |
+17,520
| New | +$258K | ﹤0.01% | 3461 |
|
|
2023
Q3 | – | Sell |
-11,189
| Closed | -$180K | – | 3830 |
|
|
2023
Q2 | $180K | Buy |
+11,189
| New | +$180K | ﹤0.01% | 3471 |
|
|
2022
Q4 | – | Sell |
-19,476
| Closed | -$168K | – | 3855 |
|
|
2022
Q3 | $168K | Sell |
19,476
-6,778
| -26% | -$58.5K | ﹤0.01% | 3463 |
|
|
2022
Q2 | $214K | Sell |
26,254
-7,413
| -22% | -$60.4K | ﹤0.01% | 3441 |
|
|
2022
Q1 | $409K | Sell |
33,667
-21,328
| -39% | -$259K | ﹤0.01% | 3170 |
|
|
2021
Q4 | $1.88M | Buy |
54,995
+767
| +1% | +$26.2K | ﹤0.01% | 2218 |
|
|
2021
Q3 | $2.62M | Sell |
54,228
-17,100
| -24% | -$825K | ﹤0.01% | 1906 |
|
|
2021
Q2 | $3.22M | Buy |
71,328
+17,621
| +33% | +$796K | ﹤0.01% | 1784 |
|
|
2021
Q1 | $2.59M | Sell |
53,707
-13,592
| -20% | -$655K | ﹤0.01% | 1841 |
|
|
2020
Q4 | $3.62M | Buy |
67,299
+1,363
| +2% | +$73.4K | ﹤0.01% | 1517 |
|
|
2020
Q3 | $2.43M | Sell |
65,936
-2,437
| -4% | -$89.9K | ﹤0.01% | 1627 |
|
|
2020
Q2 | $2.12M | Sell |
68,373
-28,593
| -29% | -$886K | ﹤0.01% | 1701 |
|
|
2020
Q1 | $2.68M | Buy |
96,966
+6,420
| +7% | +$177K | ﹤0.01% | 1410 |
|
|
2019
Q4 | $2.65M | Buy |
90,546
+22,493
| +33% | +$658K | ﹤0.01% | 1652 |
|
|
2019
Q3 | $1.3M | Buy |
68,053
+21,337
| +46% | +$408K | ﹤0.01% | 2029 |
|
|
2019
Q2 | $1.03M | Buy |
46,716
+4,144
| +10% | +$90.9K | ﹤0.01% | 2198 |
|
|
2019
Q1 | $871K | Buy |
42,572
+1,716
| +4% | +$35.1K | ﹤0.01% | 2284 |
|
|
2018
Q4 | $515K | Buy |
+40,856
| New | +$515K | ﹤0.01% | 2531 |
|
|
2017
Q4 | – | Sell |
-10,485
| Closed | -$117K | – | 3342 |
|
|
2017
Q3 | $117K | Buy |
+10,485
| New | +$117K | ﹤0.01% | 3124 |
|